Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Dutch court blocks subcutaneous Keytruda in eight European countries

A Dutch court has ordered Merck to stop manufacturing and selling its injectable formulation of Keytruda in eight European countries. The court ruled that Merck infringed one of Halozyme's patents and

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

VA Benefits Update: Trump Official Reveals Changes to Impact Overall Care

Collins said that veterans should specifically look beyond wait times and focus more on the quality of care they receive.

  • VA Secretary Collins emphasizes quality of care over wait times.
  • Record 59.99 million community care appointments in fiscal year 2025.
  • Disability claims processing time reduced to 75.6 days in September 2025.

More from Wednesday 7 October →